Citius Oncology, Inc.
CTOR
$1.89
$0.148.00%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
8/22/2025
-
GuruFocus
8/22/2025
-
GuruFocus
8/22/2025
-
PR Newswire
8/20/2025
-
MarketBeat
8/15/2025
-
MarketBeat
8/13/2025
-
Fool.com Headlines
8/12/2025
-
GuruFocus
8/12/2025
-
GuruFocus
8/12/2025
-
TipRanks Financial Blog
8/12/2025
-
PR Newswire
8/6/2025
-
CNW Group - News Releases
8/6/2025
-
PR Newswire
7/26/2025
-
MarketBeat
7/17/2025
-
GuruFocus
7/17/2025
-
GuruFocus
7/17/2025
-
PR Newswire
7/16/2025
-
GuruFocus
7/16/2025
-
GuruFocus
7/16/2025
-
Seeking Alpha - Healthcare
7/16/2025
-
PR Newswire
7/15/2025
-
Simply Wall St
7/15/2025
-
SeekingAlpha
7/15/2025
-
GuruFocus
7/15/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, August 12, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Dec 22 and 26 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
--
Phone Number
(908) 967-6677
Address
11 Commerce Drive
Cranford, NJ 07016
Cranford, NJ 07016
Country
Year Founded
--
Business Description
Sector
Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the...
more